163 related articles for article (PubMed ID: 36078943)
1. Anemia Is an Indicator for Worse Organ Damage Trajectories in Patients with Systemic Sclerosis: A Retrospective Study.
Li Z; Xu D; Jiang X; Li T; Su Y; Mu R
J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36078943
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis.
Ferdowsi N; Huq M; Stevens W; Hudson M; Wang M; Tay T; Burchell JL; Mancuso S; Rabusa C; Sundararajan V; Prior D; Proudman SM; Baron M; Nikpour M; ;
Ann Rheum Dis; 2019 Jun; 78(6):807-816. PubMed ID: 30928903
[TBL] [Abstract][Full Text] [Related]
3. Long-term organ damage accrual and late mortality in systemic sclerosis.
Lazzaroni MG; Moschetti L; Breda M; Franceschini F; Airò P
Clin Exp Rheumatol; 2023 Oct; ():. PubMed ID: 37933549
[TBL] [Abstract][Full Text] [Related]
4. Damage Trajectories in Systemic Sclerosis Using Group-Based Trajectory Modeling.
Barbacki A; Baron M; Wang M; Zhang Y; Stevens W; Sahhar J; Proudman S; Nikpour M; Man A;
Arthritis Care Res (Hoboken); 2023 Mar; 75(3):640-647. PubMed ID: 35226416
[TBL] [Abstract][Full Text] [Related]
5. Prediction of damage trajectories in systemic sclerosis using group-based trajectory modelling.
Baron M; Barbacki A; Man A; de Vries-Bouwstra JK; Johnson D; Stevens W; Osman M; Wang M; Zhang Y; Sahhar J; Ngian GS; Proudman S; Nikpour M;
Rheumatology (Oxford); 2023 Sep; 62(9):3059-3066. PubMed ID: 36625513
[TBL] [Abstract][Full Text] [Related]
6. Reliability and validity of the Korean version of the University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract instrument in patients with systemic sclerosis.
Lee TH; Lee JS; Park S; Lee KA; Kim HS
Korean J Intern Med; 2021 Nov; 36(6):1504-1514. PubMed ID: 33561335
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and correlates of sleep disturbance in systemic sclerosis--results from the UCLA scleroderma quality of life study.
Frech T; Hays RD; Maranian P; Clements PJ; Furst DE; Khanna D
Rheumatology (Oxford); 2011 Jul; 50(7):1280-7. PubMed ID: 21324979
[TBL] [Abstract][Full Text] [Related]
8. Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis.
Gualtierotti R; Ingegnoli F; Two R; Meroni PL; Khanna D; Adorni G; Becciolini A; Ciavarella T; Marfia G; Murgo A; Scalone L; Ughi N; Zeni S;
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S55-60. PubMed ID: 26339890
[TBL] [Abstract][Full Text] [Related]
9. Correction:
Ann Rheum Dis; 2019 Aug; 78(8):e88. PubMed ID: 31296652
[No Abstract] [Full Text] [Related]
10. Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity Index.
Ross L; Hansen D; Proudman S; Khanna D; Herrick AL; Stevens W; ; ; Baron M; Nikpour M;
Arthritis Rheumatol; 2024 Jun; ():. PubMed ID: 38937146
[TBL] [Abstract][Full Text] [Related]
11. Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis.
Bodukam V; Hays RD; Maranian P; Furst DE; Seibold JR; Impens A; Mayes MD; Clements PJ; Khanna D
Rheumatology (Oxford); 2011 Feb; 50(2):330-4. PubMed ID: 20884655
[TBL] [Abstract][Full Text] [Related]
12. High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis.
Abozaid HSM; Imam HMK; Abdelaziz MM; El-Hammady DH; Fathi NA; Furst DE
Semin Arthritis Rheum; 2017 Dec; 47(3):403-408. PubMed ID: 28624173
[TBL] [Abstract][Full Text] [Related]
13. Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis.
Palumbo P; Ruscitti P; Cannizzaro E; Berardicurti O; Conforti A; Di Cesare A; Di Cola I; Giacomelli R; Splendiani A; Barile A; Masciocchi C; Cipriani P; Di Cesare E
Sci Rep; 2022 Mar; 12(1):5125. PubMed ID: 35332224
[TBL] [Abstract][Full Text] [Related]
14. The assessment of malnutrition and severity of gastrointestinal disease by using symptom-based questionnaires in systemic sclerosis: is it related to severe organ involvement or capillary rarefaction at microcirculation?
Yalcinkaya Y; Erturk Z; Unal AU; Kaymaz Tahra S; Pehlivan O; Atagunduz P; Direskeneli H; Inanç N
Clin Exp Rheumatol; 2020; 38 Suppl 125(3):127-131. PubMed ID: 32141434
[TBL] [Abstract][Full Text] [Related]
15. Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
Khanna D; Hays RD; Maranian P; Seibold JR; Impens A; Mayes MD; Clements PJ; Getzug T; Fathi N; Bechtel A; Furst DE
Arthritis Rheum; 2009 Sep; 61(9):1257-63. PubMed ID: 19714600
[TBL] [Abstract][Full Text] [Related]
16. An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups.
Baron M; Kahaleh B; Bernstein EJ; Chung L; Clements PJ; Denton C; Domsic RT; Ferdowsi N; Foeldvari I; Frech T; Gordon JK; Hudson M; Johnson SR; Khanna D; McMahan Z; Merkel PA; Narain S; Nikpour M; Pauling JD; Ross L; Valenzuela Vergara AM; Vacca A
J Scleroderma Relat Disord; 2019 Feb; 4(1):17-27. PubMed ID: 30906878
[TBL] [Abstract][Full Text] [Related]
17. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.
Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin R; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold J
Arthritis Rheum; 1999 Nov; 42(11):2372-80. PubMed ID: 10555033
[TBL] [Abstract][Full Text] [Related]
18. The validity and reliability study of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire for the Turkish society.
Taş YM; Derviş Hakim G; Keskinoğlu P; Kenar G; Yarkan H; Zengin B; Can G; Önen F; Akkoç N; Birlik M; Akarsu M
Turk J Gastroenterol; 2019 Mar; 30(3):234-241. PubMed ID: 30541712
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody predictors of gastrointestinal symptoms in systemic sclerosis.
Ahmed F; Maclean RH; Nihtyanova SI; Ong VH; Murray CD; Denton CP
Rheumatology (Oxford); 2022 Feb; 61(2):781-786. PubMed ID: 33909895
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report.
Pauling JD; Frech TM; Hughes M; Gordon JK; Domsic RT; Anderson ME; Ingegnoli F; McHugh NJ; Johnson SR; Hudson M; Boin F; Ong VH; Matucci-Cerinic M; Altorok N; Scolnik M; Nikpour M; Shah A; Pope JE; Khanna D; Herrick AL
J Scleroderma Relat Disord; 2018 Oct; 3(3):249-252. PubMed ID: 30705970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
